Physician profile
Jason Hanft
NPI 1174588032
$1,906.59
in general payments reported to CMS, 2019-2025
12 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $272 · 2021: $377 · 2022: $281 · 2023: $297 · 2024: $3.59 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,025.58 | 2019-2025 | Affinity |
| Next Science LLC | $242.14 | 2022-2023 | Surgx, Blastx, Xperience |
| Djo, LLC | $194.79 | 2019-2021 | |
| Ets Wound Care LLC | $119.96 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Smith+Nephew, INC. | $85.55 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $83.21 | 2020-2022 | |
| Kci USA, INC. | $60.66 | 2020-2021 | |
| Kerecis Limited | $40.48 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bsn Medical INC | $22.29 | 2019 | |
| Alfasigma USA, INC. | $17.98 | 2021 | |
| Sebela Pharmaceuticals INC. | $13.95 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Hanft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.